Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Blumberg, J; Cadiot, G; Capdevila, J; Caplin, Me; Langley, A; Martinez, S; Pavel, M; Phan, At; Raderer, M; Rindi, Guido (ORCID:0000-0003-2996-4404); Ruszniewski, P.; Sedláčková, E; Wall, L; Wolin, Em; Ćwikła, Jb

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Authors: J Blumberg
G Cadiot
J Capdevila
Me Caplin
A Langley
S Martinez
M Pavel
At Phan
M Raderer
Guido (ORCID:0000-0003-2996-4404) Rindi
P. Ruszniewski
E Sedláčková
L Wall
Em Wolin
Jb Ćwikła
Publication date: 1 January 2014
Publisher: 'Massachusetts Medical Society'
Doi

Abstract

Somatostatin analogues are commonly used to treat symptoms associated with hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects are limited

Similar works

Full text

Available Versions

PubliCatt

oai:publicatt.unicatt.it:10807...

Last time updated on 08/03/2017